ArticleCancer research2023

Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21-CDK4/6-Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance.

Xiaoqing Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.